The implementation of a massive, statewide public health initiative led by University of Arizona researchers and involving 21,000 prehospital care patients has doubled the survival rate of severe traumatic brain injury victims and tripled the survival rate among those who were intubated.
Melissa Furlong, PhD, a postdoctoral fellow and environmental epidemiologist at the University of Arizona Mel and Enid Zuckerman College of Public Health, will study the link between pesticides and childhood attention deficit hyperactivity disorder in Arizona, with funding from the National Institute of Environmental Health Sciences.
Three graduate students from the University of Arizona Mel and Enid Zuckerman College of Public Health have received the 2019 Cancer Epidemiology Education in Special Populations Fellowship.
While antibiotic resistance is on the rise, pharmaceutical companies are making fewer and fewer new antibiotics. UA immunobiologist Michael Johnson says this trend is in urgent need of reversal and believes copper might just be the key.
UA pulmonologists and rheumatologists say the designation will increase patient referrals, improve access to clinical trials and research funding for this autoimmune rheumatic disorder that affects, by some estimates, as many as 300,000 Americans. This is only the second such center in Arizona.
The University of Arizona Health Sciences Career Development Awards program seeks to nurture the development of new clinical trials and biomedical and behavioral interventions to treat disease and the number of health scientists for our state and nation. This year the awards will fund sleep-, cancer- and cardiovascular disease-related research by four promising young investigators.
Roberta Diaz Brinton, PhD, inaugural director of the Center for Innovation in Brain Science at the University of Arizona Health Sciences, has been awarded a $1.8 million National Institutes of Health training program grant to develop a cross-disciplinary and translationally oriented workforce to discover new drugs for Alzheimer’s and other neurodegenerative diseases and shepherd them through the drug-development pipeline.
The honor recognizes Dr. Badger’s substantive research focusing on depression, symptom management and quality of life among cancer survivors and their families.
